Optimal management of hyperlipidemia in primary prevention of cardiovascular disease
- 31 December 2004
- journal article
- review article
- Published by Elsevier BV in International Journal of Cardiology
- Vol. 97 (3), 355-366
- https://doi.org/10.1016/j.ijcard.2003.07.039
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- Concomitant use of cytochrome P450 3A4 inhibitors and simvastatinThe American Journal of Cardiology, 1999
- Additional reduction in blood pressure after cholesterol-lowering treatment by statins (lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors (enalapril or lisinopril)The American Journal of Cardiology, 1999
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsThe New England Journal of Medicine, 1998
- The Kuopio Atherosclerosis Prevention Study (KAPS): Effect of pravastatin treatment on lipids, oxidation resistance of lipoprotems, and atherosclerotic progressionThe American Journal of Cardiology, 1995
- Relation of serum lipoprotein cholesterol levels to presence and severity of angiographic coronary artery diseaseThe American Journal of Cardiology, 1991
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaThe New England Journal of Medicine, 1987
- Relation of Serum Lipoprotein Levels and Systolic Blood Pressure to Early AtherosclerosisThe New England Journal of Medicine, 1986
- Effects of an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase on Serum Lipoproteins and Ubiquinone-10 Levels in Patients with Familial HypercholesterolemiaThe New England Journal of Medicine, 1981
- Cholestyramine Promotes Receptor-Mediated Low-Density-Lipoprotein CatabolismThe New England Journal of Medicine, 1980
- Colestipol hydrochloride in hypercholesterolemic patients—Effect on serum cholesterol and mortalityJournal of Chronic Diseases, 1978